Thierry Burnouf: Platelet-Derived Therapies Show Promise for Restoring Neuronal Mitochondrial Function
Thierry Burnouf, Professor of Biomedical Engineering at Taipei Medical University, has shared a post on LinkedIn:
“Our new preprint is now available on bioRxiv: ‘Human Platelet-Derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models’
This work, led by KIRTI GUPTA with contributions from Liling Delila, David Blum, Anup Pandith, and Thierry Burnouf, shows how platelet-derived formulations can restore mitochondrial activity and rebalance redox stress in models of neurodegeneration.
Mitochondrial dysfunction and oxidative stress are common hallmarks of neurodegenerative diseases. We show that two clinically compliant platelet-derived products, a purified platelet lysate (HPPL), and a population of platelet extracellular vesicles (PEVs) rescue mitochondrial activity, reduce oxidative stress, and improve neuronal survival in both cell models and zebrafish embryos.
Data confirm that outdated clinical-grade platelet concentrates can provide a safe, scalable, and locally accessible resource for developing biotherapies, even in countries with limited infrastructure for advanced biologics manufacturing.”
Title: Human Platelet-derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models
Authors: Kirti Gupta, Liling Delila, David Blum, Anup Pandith, Thierry Burnouf

Read the full article here.
More recent insights on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines